Bio Rad Laboratories, Inc. (BIO) CEO Norman Schwartz on Q3 2019 Results - Earnings Call Transcript

Bio Rad Laboratories, Inc. (NYSE:BIO) Q3 2019 Earnings Conference Call October 31, 2019 5:00 PM ET

Company Participants

Ronald Hutton - VP & Treasurer
Ilan Daskal - EVP & CFO
Norman Schwartz - Chairman, CEO & President
Andrew Last - EVP & COO
Annette Tumolo - EVP & President, Life Science Group
John Hertia - EVP & President, Clinical Diagnostics Group

Conference Call Participants

Brandon Couillard - Jefferies
Jack Meehan - Barclays Bank

Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Bio-Rad Laboratories' Third Quarter Earnings Call. [Operator Instructions].

I'd now like to hand the conference over to your speaker today, Mr. Ron Hutton, Vice President and Treasurer. Please go ahead.

Ronald Hutton

Thank you, Liz. Good afternoon, and thank you for joining us. Today, we will review the third quarter financial results for 2019. With me on the call today are Norman Schwartz, our CEO; Ilan Daskal, Executive Vice President and Chief Financial Officer; Andy Last, Executive Vice President and Chief Operating Officer; Annette Tumolo, President of the Life Science Group; and John Hertia, President of the Clinical Diagnostics Group.

Before we begin our review, I would like to caution everybody that we will be making forward-looking statements about management's goals, plans and expectations, our future financial performance and other matters. Because our actual results may differ materially from these plans and expectations, you should not place undue reliance on these forward-looking statements. And I encourage you to review our filings with the SEC, where we discuss in detail the risk factors in our business. The company does not intend to update any forward-looking statements made during the call today.

Our remarks today will also include references to non-GAAP net income and non-GAAP diluted income per share, which are financial measures that are not defined